Drugs Safety Update: changes in SABA prescribing guidelines

Please find below a Drugs Safety Update from MHRA:

Healthcare professionals and patients are reminded of the risk of severe asthma attacks and increased mortality associated with overuse of SABA with or without anti-inflammatory maintenance therapy in patients with asthma. Healthcare professionals should be aware of the change in guidance that no longer recommends prescribing SABA without an inhaled corticosteroid.

Full details can be found on the following link.

Image credit: Freepik